Immuneering a Aktie
WKN DE: A3CWDN / ISIN: US45254E1073
|
15.06.2026 13:55:03
|
Immuneering Corp Appoints Andrew Gengos As CFO
(RTTNews) - Immuneering Corporation (IMRX), a late-stage clinical oncology company, Monday announced that it has appointed Andrew Gengos as Chief Financial Officer, effective July 16.
Most recently, Gengos served as the Chief Financial Officer at Terns Pharmaceuticals, which Merck & Co., Inc. acquired for $6.7 billion.
Prior to Terns Pharmaceuticals, he was the CFO and Chief Business Officer of Athira Pharma, Inc. now LeonaBio, Inc.
In pre-market activity, IMRX shares were trading at $4.24, up 1.41% on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Immuneering Corp Registered Shs -A-
| Keine Nachrichten verfügbar. |
Analysen zu Immuneering Corp Registered Shs -A-
Aktien in diesem Artikel
| Immuneering Corp Registered Shs -A- | 4,17 | -0,48% |
|